|
Re: Broker Meeting 23 Feb
|
3
|
Zenith Epigenetics
|
Mar 01, 2017 12:50PM
|
|
Re: Whoa!
|
3
|
Zenith Epigenetics
|
Jun 18, 2020 10:36AM
|
|
Re: Confirmation bias.....
|
3
|
Resverlogix Corp.
|
May 01, 2017 09:05PM
|
|
Re: Did DM show some cards?
|
3
|
Resverlogix Corp.
|
Sep 04, 2020 09:17PM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 09:56AM
|
|
Re: Financial Future
|
3
|
Resverlogix Corp.
|
May 13, 2019 02:49PM
|
|
Re: Reverse Split Thoughts
|
3
|
Resverlogix Corp.
|
Apr 30, 2023 12:44PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 13, 2023 11:58AM
|
|
Re: Hind sight is 20/20....
|
3
|
Resverlogix Corp.
|
Jun 19, 2020 06:08PM
|
|
Re: Dated November 2oth, 2020./OT
|
3
|
Resverlogix Corp.
|
Feb 07, 2021 05:44PM
|
|
Re: Will Apabetalone end up in China first?
|
3
|
Resverlogix Corp.
|
Aug 04, 2018 05:43PM
|
|
Re: Hind sight is 20/20....
|
3
|
Resverlogix Corp.
|
Jun 19, 2020 06:23PM
|
|
Re: My one-minute commercial for Apabetalone
|
3
|
Resverlogix Corp.
|
Sep 11, 2019 04:11AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Jan 30, 2019 10:04AM
|
|
Re: Just checked the chart again....seeing another wedge
|
3
|
Resverlogix Corp.
|
Apr 04, 2019 08:17PM
|
|
Re: My estimate for Top Line Data Announcement...is a shocker!
|
3
|
Resverlogix Corp.
|
Jun 05, 2019 08:06PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Mar 28, 2017 03:07PM
|
|
Short Report
|
3
|
Resverlogix Corp.
|
Feb 15, 2019 04:23PM
|
|
Re: Many hands make light work....
|
3
|
Resverlogix Corp.
|
Aug 21, 2018 09:32PM
|
|
The offering
|
3
|
Resverlogix Corp.
|
May 23, 2019 12:54PM
|
